Responses
Hemorrhagic Stroke
Original research
Periprocedural to 1-year safety and efficacy outcomes with the Pipeline Embolization Device with Shield technology for intracranial aneurysms: a prospective, post-market, multi-center study
Compose a Response to This Article
Other responses
No responses have been published for this article.